- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.41 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 8 x OK8: (2~{S})-2-[[5-azanyl-1-[(2~{R},3~{R},4~{S},5~{R})-3,4-bis(oxidanyl)-5-(phosphonooxymethyl)oxolan-2-yl]imidazol-4-yl]car bonylamino]butanedioic acid(Non-covalent)
OK8.2: 19 residues within 4Å:- Chain A: K.17, T.40, A.41, G.42, E.97, V.99, R.101, G.106, S.107, D.189, M.190, K.191, D.212, S.213, W.214, R.215, K.228, R.232
- Ligands: MG.8
18 PLIP interactions:18 interactions with chain A- Hydrogen bonds: A:G.42, A:S.107, A:S.107, A:D.189, A:D.212, A:W.214, A:R.232, A:R.232
- Water bridges: A:T.40, A:S.107, A:K.228, A:K.228
- Salt bridges: A:K.17, A:R.101, A:R.215, A:K.228, A:K.228, A:R.232
OK8.11: 20 residues within 4Å:- Chain B: K.17, T.40, A.41, G.42, E.97, V.99, R.101, T.105, G.106, S.107, D.189, M.190, K.191, D.212, S.213, W.214, R.215, K.228, R.232
- Ligands: MG.14
20 PLIP interactions:20 interactions with chain B- Hydrogen bonds: B:G.42, B:G.42, B:S.107, B:D.137, B:D.189, B:D.212, B:R.232, B:R.232
- Water bridges: B:S.107, B:S.107, B:D.212, B:W.214, B:R.215, B:R.215
- Salt bridges: B:K.17, B:R.101, B:R.215, B:K.228, B:K.228, B:R.232
OK8.16: 19 residues within 4Å:- Chain C: K.17, T.40, A.41, G.42, E.97, V.99, R.101, G.106, S.107, D.189, M.190, K.191, D.212, S.213, W.214, R.215, K.228, R.232
- Ligands: MG.22
18 PLIP interactions:18 interactions with chain C- Hydrogen bonds: C:G.42, C:S.107, C:S.107, C:D.189, C:D.212, C:W.214, C:R.232, C:R.232
- Water bridges: C:T.40, C:S.107, C:K.228, C:K.228
- Salt bridges: C:K.17, C:R.101, C:R.215, C:K.228, C:K.228, C:R.232
OK8.25: 20 residues within 4Å:- Chain D: K.17, T.40, A.41, G.42, E.97, V.99, R.101, T.105, G.106, S.107, D.189, M.190, K.191, D.212, S.213, W.214, R.215, K.228, R.232
- Ligands: MG.28
20 PLIP interactions:20 interactions with chain D- Hydrogen bonds: D:G.42, D:G.42, D:S.107, D:D.137, D:D.189, D:D.212, D:R.232, D:R.232
- Water bridges: D:S.107, D:S.107, D:D.212, D:W.214, D:R.215, D:R.215
- Salt bridges: D:K.17, D:R.101, D:R.215, D:K.228, D:K.228, D:R.232
OK8.30: 19 residues within 4Å:- Chain E: K.17, T.40, A.41, G.42, E.97, V.99, R.101, G.106, S.107, D.189, M.190, K.191, D.212, S.213, W.214, R.215, K.228, R.232
- Ligands: MG.36
18 PLIP interactions:18 interactions with chain E- Hydrogen bonds: E:T.40, E:G.42, E:S.107, E:S.107, E:D.189, E:D.212, E:W.214, E:R.232, E:R.232
- Water bridges: E:S.107, E:K.228, E:K.228
- Salt bridges: E:K.17, E:R.101, E:R.215, E:K.228, E:K.228, E:R.232
OK8.39: 20 residues within 4Å:- Chain F: K.17, T.40, A.41, G.42, E.97, V.99, R.101, T.105, G.106, S.107, D.189, M.190, K.191, D.212, S.213, W.214, R.215, K.228, R.232
- Ligands: MG.42
20 PLIP interactions:20 interactions with chain F- Hydrogen bonds: F:T.40, F:G.42, F:G.42, F:S.107, F:D.189, F:D.212, F:R.232, F:R.232
- Water bridges: F:S.107, F:S.107, F:D.212, F:W.214, F:R.215, F:R.215
- Salt bridges: F:K.17, F:R.101, F:R.215, F:K.228, F:K.228, F:R.232
OK8.44: 19 residues within 4Å:- Chain G: K.17, T.40, A.41, G.42, E.97, V.99, R.101, G.106, S.107, D.189, M.190, K.191, D.212, S.213, W.214, R.215, K.228, R.232
- Ligands: MG.50
18 PLIP interactions:18 interactions with chain G- Hydrogen bonds: G:T.40, G:G.42, G:S.107, G:S.107, G:D.189, G:D.212, G:W.214, G:R.232, G:R.232
- Water bridges: G:S.107, G:K.228, G:K.228
- Salt bridges: G:K.17, G:R.101, G:R.215, G:K.228, G:K.228, G:R.232
OK8.53: 20 residues within 4Å:- Chain H: K.17, T.40, A.41, G.42, E.97, V.99, R.101, T.105, G.106, S.107, D.189, M.190, K.191, D.212, S.213, W.214, R.215, K.228, R.232
- Ligands: MG.56
21 PLIP interactions:21 interactions with chain H- Hydrogen bonds: H:T.40, H:G.42, H:G.42, H:S.107, H:D.189, H:D.212, H:R.232, H:R.232
- Water bridges: H:E.97, H:S.107, H:S.107, H:D.212, H:W.214, H:R.215, H:R.215
- Salt bridges: H:K.17, H:R.101, H:R.215, H:K.228, H:K.228, H:R.232
- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 7 residues within 4Å:- Chain A: K.178, E.263, G.392, L.393, S.394, N.395, H.396
Ligand excluded by PLIPEDO.4: 7 residues within 4Å:- Chain A: I.73, K.74, I.164, F.194, I.203, L.205, I.411
Ligand excluded by PLIPEDO.5: 6 residues within 4Å:- Chain A: V.377, L.378, S.379
- Chain B: L.366, R.367, L.368
Ligand excluded by PLIPEDO.6: 6 residues within 4Å:- Chain A: E.317, G.318, D.319, G.320
- Chain B: E.177, K.178
Ligand excluded by PLIPEDO.9: 7 residues within 4Å:- Chain A: E.177, K.178, L.181
- Chain B: E.317, G.318, D.319, G.320
Ligand excluded by PLIPEDO.12: 2 residues within 4Å:- Chain B: S.274, T.275
Ligand excluded by PLIPEDO.17: 7 residues within 4Å:- Chain C: K.178, E.263, G.392, L.393, S.394, N.395, H.396
Ligand excluded by PLIPEDO.18: 7 residues within 4Å:- Chain C: I.73, K.74, I.164, F.194, I.203, L.205, I.411
Ligand excluded by PLIPEDO.19: 6 residues within 4Å:- Chain C: V.377, L.378, S.379
- Chain D: L.366, R.367, L.368
Ligand excluded by PLIPEDO.20: 6 residues within 4Å:- Chain C: E.317, G.318, D.319, G.320
- Chain D: E.177, K.178
Ligand excluded by PLIPEDO.23: 7 residues within 4Å:- Chain C: E.177, K.178, L.181
- Chain D: E.317, G.318, D.319, G.320
Ligand excluded by PLIPEDO.26: 2 residues within 4Å:- Chain D: S.274, T.275
Ligand excluded by PLIPEDO.31: 7 residues within 4Å:- Chain E: K.178, E.263, G.392, L.393, S.394, N.395, H.396
Ligand excluded by PLIPEDO.32: 7 residues within 4Å:- Chain E: I.73, K.74, I.164, F.194, I.203, L.205, I.411
Ligand excluded by PLIPEDO.33: 6 residues within 4Å:- Chain E: V.377, L.378, S.379
- Chain F: L.366, R.367, L.368
Ligand excluded by PLIPEDO.34: 6 residues within 4Å:- Chain E: E.317, G.318, D.319, G.320
- Chain F: E.177, K.178
Ligand excluded by PLIPEDO.37: 7 residues within 4Å:- Chain E: E.177, K.178, L.181
- Chain F: E.317, G.318, D.319, G.320
Ligand excluded by PLIPEDO.40: 2 residues within 4Å:- Chain F: S.274, T.275
Ligand excluded by PLIPEDO.45: 7 residues within 4Å:- Chain G: K.178, E.263, G.392, L.393, S.394, N.395, H.396
Ligand excluded by PLIPEDO.46: 7 residues within 4Å:- Chain G: I.73, K.74, I.164, F.194, I.203, L.205, I.411
Ligand excluded by PLIPEDO.47: 6 residues within 4Å:- Chain G: V.377, L.378, S.379
- Chain H: L.366, R.367, L.368
Ligand excluded by PLIPEDO.48: 6 residues within 4Å:- Chain G: E.317, G.318, D.319, G.320
- Chain H: E.177, K.178
Ligand excluded by PLIPEDO.51: 7 residues within 4Å:- Chain G: E.177, K.178, L.181
- Chain H: E.317, G.318, D.319, G.320
Ligand excluded by PLIPEDO.54: 2 residues within 4Å:- Chain H: S.274, T.275
Ligand excluded by PLIP- 16 x MG: MAGNESIUM ION(Non-covalent)
MG.7: 2 residues within 4Å:- Chain A: D.207
- Ligands: ANP.1
No protein-ligand interaction detected (PLIP)MG.8: 3 residues within 4Å:- Chain A: E.97, D.137
- Ligands: OK8.2
2 PLIP interactions:2 interactions with chain A- Metal complexes: A:E.97, A:D.137
MG.13: 2 residues within 4Å:- Chain B: D.207
- Ligands: ANP.10
No protein-ligand interaction detected (PLIP)MG.14: 3 residues within 4Å:- Chain B: E.97, D.137
- Ligands: OK8.11
3 PLIP interactions:2 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:E.97, B:D.137, H2O.11
MG.21: 2 residues within 4Å:- Chain C: D.207
- Ligands: ANP.15
No protein-ligand interaction detected (PLIP)MG.22: 3 residues within 4Å:- Chain C: E.97, D.137
- Ligands: OK8.16
2 PLIP interactions:2 interactions with chain C- Metal complexes: C:E.97, C:D.137
MG.27: 2 residues within 4Å:- Chain D: D.207
- Ligands: ANP.24
No protein-ligand interaction detected (PLIP)MG.28: 3 residues within 4Å:- Chain D: E.97, D.137
- Ligands: OK8.25
3 PLIP interactions:2 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:E.97, D:D.137, H2O.22
MG.35: 2 residues within 4Å:- Chain E: D.207
- Ligands: ANP.29
No protein-ligand interaction detected (PLIP)MG.36: 3 residues within 4Å:- Chain E: E.97, D.137
- Ligands: OK8.30
2 PLIP interactions:2 interactions with chain E- Metal complexes: E:E.97, E:D.137
MG.41: 2 residues within 4Å:- Chain F: D.207
- Ligands: ANP.38
No protein-ligand interaction detected (PLIP)MG.42: 3 residues within 4Å:- Chain F: E.97, D.137
- Ligands: OK8.39
3 PLIP interactions:2 interactions with chain F, 1 Ligand-Water interactions- Metal complexes: F:E.97, F:D.137, H2O.33
MG.49: 2 residues within 4Å:- Chain G: D.207
- Ligands: ANP.43
No protein-ligand interaction detected (PLIP)MG.50: 3 residues within 4Å:- Chain G: E.97, D.137
- Ligands: OK8.44
2 PLIP interactions:2 interactions with chain G- Metal complexes: G:E.97, G:D.137
MG.55: 2 residues within 4Å:- Chain H: D.207
- Ligands: ANP.52
No protein-ligand interaction detected (PLIP)MG.56: 3 residues within 4Å:- Chain H: E.97, D.137
- Ligands: OK8.53
3 PLIP interactions:2 interactions with chain H, 1 Ligand-Water interactions- Metal complexes: H:E.97, H:D.137, H2O.44
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Skerlova, J. et al., Crystal structures of human PAICS reveal substrate and product binding of an emerging cancer target. J.Biol.Chem. (2020)
- Release Date
- 2020-07-08
- Peptides
- Multifunctional protein ADE2: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
BG
AH
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.41 Å
- Oligo State
- homo-octamer
- Ligands
- 8 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 8 x OK8: (2~{S})-2-[[5-azanyl-1-[(2~{R},3~{R},4~{S},5~{R})-3,4-bis(oxidanyl)-5-(phosphonooxymethyl)oxolan-2-yl]imidazol-4-yl]car bonylamino]butanedioic acid(Non-covalent)
- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 16 x MG: MAGNESIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Skerlova, J. et al., Crystal structures of human PAICS reveal substrate and product binding of an emerging cancer target. J.Biol.Chem. (2020)
- Release Date
- 2020-07-08
- Peptides
- Multifunctional protein ADE2: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
BE
AF
BG
AH
B